The Process Development Blog

Subtle changes in particle size, shape, and distribution can have a major impact on pharmaceutical solubility and stability. Moreover, low bulk densities can cause flow and formulation challenges during processing.

Good crystallization process design, for intermediates or final APIs, can save you months of time during development. However, crystallization of stereoisomers can be particularly challenging.

In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.